SIERRA AKINWUMI: Open Payments
NPI 1922757384 · GREENCASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,378 in 50 payments from 24 companies in 2025. Trend: 2023 $1,828 · 2024 $3,358 · 2025 $2,378
Food & beverage: $2,288Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $550 |
| Incyte Corporation | 6 | $440 |
| PFIZER INC. | 2 | $244 |
| Amgen Inc. | 1 | $150 |
| Stemline Therapeutics Inc. | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Daiichi Sankyo Inc. | 4 | $104 |
| Janssen Biotech, Inc. | 1 | $92 |
| BeiGene USA, Inc. | 1 | $82 |
| ABBVIE INC. | 3 | $63 |
Products named: ENHERTU, ADCETRIS, JAKAFI, IMDELLTRA (AMG757), Monjuvi, Zynyz, IMFINZI, Orserdu.
Industry payments across IN — which companies pay providers there.
